rs2286900
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_130759.4(GIMAP1):c.*32G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0998 in 1,475,006 control chromosomes in the GnomAD database, including 7,735 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1010 hom., cov: 32)
Exomes 𝑓: 0.099 ( 6725 hom. )
Consequence
GIMAP1
NM_130759.4 3_prime_UTR
NM_130759.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.01
Publications
18 publications found
Genes affected
GIMAP1 (HGNC:23237): (GTPase, IMAP family member 1) This gene encodes a protein belonging to the GTP-binding superfamily and to the immuno-associated nucleotide (IAN) subfamily of nucleotide-binding proteins. In humans, the IAN subfamily genes are located in a cluster at 7q36.1. This gene is thought to be involved in the differentiation of T helper (Th) cells of the Th1 lineage, and the related mouse gene has been shown to be critical for the development of mature B and T lymphocytes. Read-through transcription exists between this gene and the downstream GIMAP5 (GTPase, IMAP family member 5) gene. [provided by RefSeq, Dec 2010]
GIMAP1-GIMAP5 (HGNC:51257): (GIMAP1-GIMAP5 readthrough) This locus represents naturally occurring readthrough transcription between the neighboring GIMAP1 (GTPase, IMAP family member 1) and GIMAP5 (GTPase, IMAP family member 5) genes on chromosome 7. Alternative splicing results in multiple readthrough transcript variants, one of which encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GIMAP1 | NM_130759.4 | c.*32G>A | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000307194.6 | NP_570115.1 | ||
| GIMAP1-GIMAP5 | NM_001199577.2 | c.402+551G>A | intron_variant | Intron 3 of 5 | NP_001186506.1 | |||
| GIMAP1-GIMAP5 | NM_001303630.2 | c.18+1867G>A | intron_variant | Intron 2 of 4 | NP_001290559.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GIMAP1 | ENST00000307194.6 | c.*32G>A | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_130759.4 | ENSP00000302833.5 | |||
| GIMAP1-GIMAP5 | ENST00000611999.4 | c.402+551G>A | intron_variant | Intron 3 of 5 | 5 | ENSP00000477920.1 |
Frequencies
GnomAD3 genomes AF: 0.109 AC: 16524AN: 152094Hom.: 1010 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16524
AN:
152094
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.109 AC: 14504AN: 133184 AF XY: 0.106 show subpopulations
GnomAD2 exomes
AF:
AC:
14504
AN:
133184
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0988 AC: 130675AN: 1322794Hom.: 6725 Cov.: 28 AF XY: 0.0987 AC XY: 63901AN XY: 647636 show subpopulations
GnomAD4 exome
AF:
AC:
130675
AN:
1322794
Hom.:
Cov.:
28
AF XY:
AC XY:
63901
AN XY:
647636
show subpopulations
African (AFR)
AF:
AC:
3490
AN:
27814
American (AMR)
AF:
AC:
2671
AN:
26694
Ashkenazi Jewish (ASJ)
AF:
AC:
1591
AN:
19150
East Asian (EAS)
AF:
AC:
6875
AN:
36022
South Asian (SAS)
AF:
AC:
6643
AN:
67368
European-Finnish (FIN)
AF:
AC:
3809
AN:
35410
Middle Eastern (MID)
AF:
AC:
384
AN:
4014
European-Non Finnish (NFE)
AF:
AC:
99783
AN:
1051590
Other (OTH)
AF:
AC:
5429
AN:
54732
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
5608
11216
16825
22433
28041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3850
7700
11550
15400
19250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.109 AC: 16552AN: 152212Hom.: 1010 Cov.: 32 AF XY: 0.109 AC XY: 8149AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
16552
AN:
152212
Hom.:
Cov.:
32
AF XY:
AC XY:
8149
AN XY:
74438
show subpopulations
African (AFR)
AF:
AC:
5271
AN:
41516
American (AMR)
AF:
AC:
1488
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
305
AN:
3470
East Asian (EAS)
AF:
AC:
1020
AN:
5172
South Asian (SAS)
AF:
AC:
488
AN:
4826
European-Finnish (FIN)
AF:
AC:
1141
AN:
10608
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6494
AN:
67990
Other (OTH)
AF:
AC:
243
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
762
1524
2286
3048
3810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
545
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.